A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence

J Clin Psychiatry. 1990 Apr:51 Suppl:14-20; discussion 21.

Abstract

The electrophysiologic assessment of the action of different types of antidepressant treatments on the serotonin (5-hydroxytryptamine [5-HT]) system revealed as a common effect an enhancement of 5-HT neurotransmission, albeit each treatment achieved this result via a different mechanism. Tricyclic antidepressant drugs and electroconvulsive shock treatment sensitize postsynaptic neurons to 5-HT. Monoamine oxidase inhibitors enhance the availability of releasable 5-HT. Serotonin reuptake blockers increase the efficacy of 5-HT neurons by desensitizing 5-HT autoreceptors located on 5-HT nerve terminals. Serotonin1A receptor agonists would enhance the tonic activation of postsynaptic 5-HT1A receptors. Such results suggest that this effect of antidepressant treatments on the 5-HT system might be intimately related to their therapeutic effect in major depression.

Publication types

  • Review

MeSH terms

  • Antidepressive Agents, Tricyclic / pharmacology*
  • Depressive Disorder / drug therapy
  • Depressive Disorder / therapy
  • Electroconvulsive Therapy*
  • Humans
  • Monoamine Oxidase Inhibitors / pharmacology
  • Neurotransmitter Uptake Inhibitors*
  • Receptors, Serotonin / drug effects
  • Receptors, Serotonin / physiology
  • Serotonin / physiology*
  • Serotonin Antagonists / pharmacology
  • Synaptic Transmission / physiology

Substances

  • Antidepressive Agents, Tricyclic
  • Monoamine Oxidase Inhibitors
  • Neurotransmitter Uptake Inhibitors
  • Receptors, Serotonin
  • Serotonin Antagonists
  • Serotonin